We are live on !
Find out more
Xponance Portfolio holdings
AUM
$16.3B
Turnover
12.69%
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter Est. Return
+29.51%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$16.3B
AUM Growth
+$2.23B
(+16%)
Cap. Flow
-$15.3M
Cap. Flow % of AUM
Cap. Flow %
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
37.34%
Holding
1,883
New
197
Increased
1,009
Reduced
634
Closed
42
Avg Time Held
3.4
years
Top 10 Avg Time Held
4.7
years
Top 20 Avg Time Held
3.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$80.6M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$76.3M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$57.8M |
| 4 |
Caterpillar
CAT
|
+$32.2M |
| 5 |
Applied Materials
AMAT
|
+$26.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$149M |
| 2 |
Amazon
AMZN
|
+$128M |
| 3 |
Microsoft
MSFT
|
+$121M |
| 4 |
AbbVie
ABBV
|
+$34.6M |
| 5 |
Costco
COST
|
+$25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.2% |
| 2 | Communication Services | 10.83% |
| 3 | Financials | 10.29% |
| 4 | Consumer Discretionary | 9.28% |
| 5 | Industrials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1401
Dana Inc
DAN
$3.14B
| $301K | ﹤0.01% |
11,045
+211
| +2% | +$7.2K |
2025 Q2
4 quarters
|
|
1402
Upstart Holdings
UPST
$2.3B
| $300K | ﹤0.01% |
8,472
+388
| +5% | +$12K |
2024 Q3
7 quarters
|
|
1403
Urban Edge Properties
UE
$2.46B
| $300K | ﹤0.01% |
13,113
+1,012
| +8% | +$22.3K |
2025 Q3
3 quarters
|
|
1404
Park National Corp
PRK
$3.26B
| $300K | ﹤0.01% |
1,637
+214
| +15% | +$37K |
2026 Q1
1 quarter
|
|
1405
MarketAxess Holdings
MKTX
$5.79B
| $299K | ﹤0.01% |
2,634
-135
| -5% | -$19.2K |
2020 Q2
24 quarters
|
|
1406
Chesapeake Utilities
CPK
$3.29B
| $299K | ﹤0.01% |
2,440
+232
| +11% | +$29.1K |
2025 Q1
5 quarters
|
|
1407
Relay Therapeutics
RLAY
$4.04B
| $299K | ﹤0.01% |
15,963
+3,111
| +24% | +$45.2K |
2025 Q2
4 quarters
|
|
1408
Dyne Therapeutics
DYN
$3.04B
| $298K | ﹤0.01% |
13,436
+1,228
| +10% | +$22.8K |
2026 Q1
1 quarter
|
|
1409
Shell
SHEL
$300B
| $298K | ﹤0.01% |
+3,839
| New | +$331K |
2026 Q2
0 quarters
|
|
1410
ING
ING
$93.6B
| $297K | ﹤0.01% |
+9,477
| New | +$280K |
2026 Q2
0 quarters
|
|
1411
Arcutis Biotherapeutics
ARQT
$4.13B
| $296K | ﹤0.01% |
11,287
+202
| +2% | +$4.71K |
2025 Q4
2 quarters
|
|
1412
CoreCivic
CXW
$3B
| $294K | ﹤0.01% |
+9,666
| New | +$219K |
2026 Q2
0 quarters
|
|
1413
Rogers Corp
ROG
$2.44B
| $292K | ﹤0.01% |
+1,785
| New | +$245K |
2026 Q2
0 quarters
|
|
1414
American Eagle Outfitters
AEO
$2.98B
| $290K | ﹤0.01% |
16,885
+579
| +4% | +$10K |
2023 Q2
12 quarters
|
|
1415
WaFd
WAFD
$2.12B
| $289K | ﹤0.01% |
7,541
+233
| +3% | +$8.21K |
2026 Q1
1 quarter
|
|
1416
Nebius Group N.V.
NBIS
$46.6B
| $289K | ﹤0.01% |
+1,045
| New | +$207K |
2026 Q2
0 quarters
|
|
1417
Patrick Industries
PATK
$2.15B
| $288K | ﹤0.01% |
3,213
-259
| -7% | -$24.7K |
2023 Q4
10 quarters
|
|
1418
Aehr Test Systems
AEHR
$2.02B
| $288K | ﹤0.01% |
+2,997
| New | +$274K |
2026 Q2
0 quarters
|
|
1419
Celldex Therapeutics
CLDX
$2.38B
| $288K | ﹤0.01% |
+7,736
| New | +$250K |
2026 Q2
0 quarters
|
|
1420
H2O America
HTO
$2.38B
| $287K | ﹤0.01% |
4,724
+520
| +12% | +$30.1K |
2026 Q1
1 quarter
|
|
1421
Westlake Corp
WLK
$8.01B
| $287K | ﹤0.01% |
3,928
-60
| -2% | -$5.86K |
2022 Q4
14 quarters
|
|
1422
Acadia Realty Trust
AKR
$2.54B
| $287K | ﹤0.01% |
13,706
+1,138
| +9% | +$24.3K |
2025 Q2
4 quarters
|
|
1423
Dynex Capital
DX
$2.72B
| $286K | ﹤0.01% |
21,805
+3,834
| +21% | +$50.4K |
2025 Q3
3 quarters
|
|
1424
Mercury Insurance
MCY
$5.82B
| $286K | ﹤0.01% |
2,681
+176
| +7% | +$17.3K |
2026 Q1
1 quarter
|
|
1425
Edgewise Therapeutics
EWTX
$4.32B
| $286K | ﹤0.01% |
+7,027
| New | +$242K |
2026 Q2
0 quarters
|
|
Similar funds
NMO
Xponance's Q2 2026 Portfolio in Review
As of Q2 2026, Xponance held 1,883 positions worth $16.3B, up 16% from $14.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Xponance's Q2 2026 filing shows 197 new, 1,009 increased, 634 reduced and 42 closed positions. Its largest new stake was SpaceX: 114,259 shares worth $19.5M. The largest sale was Apple, an estimated $149M.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 36% a quarter earlier, followed by Communication Services and Financials.
- Xponance's largest Q2 2026 buy was SpaceX: 114,259 shares worth $19.5M.
- Xponance added most to Micron Technology in Q2 2026, an estimated $80.6M increase.
- Xponance's biggest Q2 2026 reduction was Apple, cutting an estimated $149M.
- Xponance fully exited Coterra Energy in Q2 2026, selling an estimated $4.27M.
- Xponance's ten largest holdings make up 37% of its $16.3B portfolio in Q2 2026.
- Xponance opened 197 new positions and closed 42 in Q2 2026.
- Xponance's portfolio value rose 16% quarter-over-quarter to $16.3B.
Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.